Olmesartan‐induced gastritis with no lower gastrointestinal symptoms: A case report
DEN Open, Volume 6, Issue 1, April 2026.Abstract A 74‐year‐old man with decreased appetite, weight, and heartburn was referred to our hospital. His medications included olmesartan. Esophagogastroduodenoscopy (EGD) revealed antral‐dominant erosive gastritis and nodular mucosa. A gastric biopsy revealed inflammatory cell infiltration.
Satoshi Kosaka +2 more
wiley +1 more source
QTc Interval Prolongation and Associated Drug Therapy in Hospitalized Older Adults
Journal of the American Geriatrics Society, EarlyView.
Francesco Fantin +7 more
wiley +1 more source
Comparison of Tegoprazan- and Lansoprazole-Based Fourteen-Day Triple Therapies as First-Line Treatments for Eradication [PDF]
The Korean Journal of Helicobacter and Upper Gastrointestinal ResearchObjectives Tegoprazan, a novel potassium-competitive acid blocker with rapid and effective antisecretory activity, was approved for the treatment of Helicobacter pylori infections in Korea in March 2020.
Seokin Kang +6 more
doaj +1 more source
Implications of Long-term Proton Pump Inhibitor Use: Promoting Step-Down Therapy for Management of Gastro-esophageal Reflux Disease in the Outpatient Setting [PDF]
, 2015 Per the International Montreal Consensus, gastro-esophageal reflux disease (GERD) is defined as a condition which develops when the reflux of stomach contents causes troublesome symptoms or complications .
Kapadia, Sonam
core +1 more source
Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial [PDF]
, 2010 Introduction Antibiotic resistance decreases success of Helicobacter pylori (Hp) eradication. Recently published results show low rate of resistance and better compliance with moxifloxacin based regiments.
Josip Bago +7 more
core +2 more sources
The effect of lansoprazole administration during pregnancy on the placenta
Journal of Basic Research in Medical Sciences, 2017 Introduction: Lansoprazole is one of the proton pump inhibitor drugs widely used in the treatment of gastro-duodenal ulcers and disorders. However, there is not enough data about unexplored adverse effects of lansoprazole on the integrity of the ...
Ali Louei Monfared, Morteza Shamsi
doaj
Kosten en effecten van esomeprazol in de behandeling van reflux ziekte [PDF]
, 2002 Doel. Het bepalen van de kosten-effectiviteit van esomeprazol (Nexium(r)) ten opzichte van alle andere in Nederland geregistreerde protonpomp remmers in de behandeling van reflux ziekte.
Al, M.J. (Maiwenn) +2 more
core
In Vitro Evaluation of Eslicarbazepine Delivery via Enteral Feeding Tubes [PDF]
, 2017 Purpose: The feasibility of preparing an eslicarbazepine acetate suspension using Aptiom tablets for administration via enteral feeding tubes was evaluated.
Dave, Vivek S +3 more
core +2 more sources
Journal of Translational Medicine, 2011 Background The treatment of human cancer has been seriously hampered for decades by resistance to chemotherapeutic drugs. Mechanisms underlying this resistance are far from being entirely known.
Spugnini Enrico P +9 more
doaj +1 more source